Papers/PMID:35237893
Randomized controlled trial of astaxanthin impacts on antioxidant status and assisted reproductive technology outcomes in women with polycystic ovarian syndrome.
Journal of assisted reproduction and genetics2022The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
astaxanthin — increases total antioxidant capacity
Evidence strength: very limited.Finding“According to our findings, a 40-day course of AST supplementation led to significantly higher levels of serum CAT and TAC in the AST group compared to the placebo group.”
Quoted verbatim from Randomized controlled trial of astaxanthin impacts on antioxidant status and assisted reproductive technology outcomes in women with polycystic ovarian syndrome.. - Study
- RCT
- Duration
- 6 weeks
- Dose
- 8 mg astaxanthin daily
- Population
- Women with polycystic ovary syndrome in a double-blind placebo-controlled trial of assisted reproductive technology outcomes
Randomized controlled trial of astaxanthin impacts on antioxidant status and assisted reproductive technology outcomes in women with polycystic ovarian syndrome.2022PMID:3523789310.1007/s10815-022-02432-0Permalink